Role of arachidonic acid metabolism on corticotropin-releasing factor (CRF)-release induced by interleukin-1 from superfused rat hypothalami.
The present work shows that the corticotropin-releasing factor (CRF)-releasing activity of interleukin-1 (IL-1) is partially inhibited by a phospholipase A2 (mepacrine) or a cyclooxygenase (indomethacin) inhibitor, but is not affected by inhibition of the lypoxygenase pathway with norhydroguaiaretic acid. These results indicate that the metabolism of arachidonic acid plays an important role as mediator of the effects of IL-1 on CRF release. It is also shown that products of the cyclooxygenase activity such as prostaglandins can stimulate CRF secretion by a direct action on the hypothalamus. Whereas PGE2 failed to induce increases on CRF release, PGF2 alpha stimulated in a dose-dependent manner (21-340 nM), the CRF release from continuous perifused hypothalami. It is suggested that PGF2 alpha could be involved as a messenger in the hypothalamic CRF secretion induced by IL-1.
Cambronero
J C
JC
Department of Psychobiology, Cajal Institute, CSIC, Madrid, Spain.
Rivas
F J
FJ
Borrell
J
J
Guaza
C
C
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism*; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism*; D015237:Dinoprost / Q000494:pharmacology; D007031:Hypothalamus / Q000378:metabolism*; D007213:Indomethacin / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology*; D008297:Male; D010477:Perfusion / Q000379:methods; D011796:Quinacrine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains
D007375:Interleukin-1; D016718:Arachidonic Acid; D003346:Corticotropin-Releasing Hormone; D015237:Dinoprost; D011796:Quinacrine; D007213:Indomethacin